Abametapir
Back to searchMolecule Structure
Scientific Name
Abametapir
Description of the Drug
Abametapir is a pediculicide metalloproteinase used topically in the treatment of head lice infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11932
http://www.drugbank.ca/drugs/DB11932
Brand Name(s)
Xeglyze
Company Owner(s)
Hatchtech Pty Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Iron | METAL | SEQUESTERING AGENT | CHEMBL2363058 |
| Copper | METAL | SEQUESTERING AGENT | CHEMBL2363057 |
| Zinc | METAL | SEQUESTERING AGENT | CHEMBL2363056 |
| Metalloproteinase | UNKNOWN | INHIBITOR | CHEMBL4495552 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL351152 |
| Human Metabolome Database | HMDB0246854 |
| DrugBank | DB11932 |
| PubChem: Thomson Pharma | 15959449 |
| PubChem | 15664 |
| Mcule | MCULE-8581798506 |
| Nikkaji | J23.945C |
| PDBe | EI3 |
| BindingDB | 50401351 |
| EPA CompTox Dashboard | DTXSID00170095 |
| DrugCentral | 5403 |
| ChemicalBook | CB4764522 |
| ChEBI | 192617 |
| ZINC | ZINC000000403335 |
